Replies to post #211497 on Biotech Values

[DewDiligence]

RVNC—The proprietary peptide in RT002’s formulation reduces (but does not eliminate) post-injection diffusion of the toxin, so more toxin remains at the injection site, which is where you want it for the desired therapeutic or cosmetic effect. What injectors and users perceive as RT002’s longer duration of action is actually slower loss of toxin at the injection site, compared to Botox and other commercial botulinum-toxin products.